Kaken Pharmaceutical Co Limited

Contact Details: 1 Hinode Urayasu-shi Chiba 279 Japan Tel: 81 0 473 90 6111 Fax: 00 81 0 473 90 6156 Email:

Recent Publications by Kaken Pharmaceutical Co Limited:
Improvement of dissolution property of poorly water-soluble drug by supercritical freeze granulation. The dissolution property of the poorly water-soluble drug, flurbiprofen...	6th October, 2009	Drug Formulation Department, Central Research Laboratories, Kaken	Chem Pharm Bull (Tokyo). 2009 Oct;57(10):1040-4.
The effects of inhaled KP-496, a novel dual antagonist for cysteinyl leukotriene receptor and thromboxane A(2) receptor, on allergic asthmatic responses in guinea pigs. AIMS: The aim of this study was to evaluate the effects of inhaled KP-496,...	25th September, 2009	Department of Pharmacology, Central Research Laboratories, Kaken	Pharmacology. 2009;84(4):249-56. Epub 2009 Sep 24. DOI Direct Link
Effects of KP-496, a novel dual antagonist for cysteinyl leukotriene receptor 1 and thromboxane A2 receptor, on Sephadex-induced airway inflammation in rats. Bronchial asthma is characterized by chronic airway inflammation....	25th July, 2009	Pharmacology Department, Central Research Laboratories, Kaken	Biol Pharm Bull. 2009 Jun;32(6):1057-61.
Improvement of dissolution property of poorly water-soluble drug by novel dry coating method using planetary ball mill. The dissolution property of a poorly water-soluble drug, flurbiprofen...	22nd October, 2008	Drug Formulation Department, Central Research Laboratories, Kaken	Chem Pharm Bull (Tokyo). 2008 Sep;56(9):1243-7.
Effects of KP-496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A(2) receptor, on airway obstruction in guinea pigs. BACKGROUND AND PURPOSE: KP-496 is a novel dual antagonist for cysteinyl...	15th May, 2008	Pharmacology Department, Central Research Laboratories, Kaken	Br J Pharmacol. 2008 Feb;153(4):669-75. Epub 2007 Nov 26. DOI Direct Link
→View more Kaken Pharmaceutical Co Limited research publications.

BioNews Results for Kaken Pharmaceutical Co Limited:
Kaken Pharmaceutical 4521.T-6mth group results	Reuters:  Nov 5 2009 4:40AM Matching: kaken pharmaceutical

Kaken Pharmaceutical Co Limited Patents:
US Patent No.	Title
5391807	Methods of preparing fluorobenzene derivatives and related compounds
5668147	Quinolinecarboxylic acid derivatives and salts thereof
5672597	Acetamide derivative
5679707	Preparation for treating wounds or hemorrhoids
5716969	Azolylamine derivative
→View more Kaken Pharmaceutical Co Limited patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 23 individuals from Kaken Pharmaceutical Co Limited using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 736 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: KAKEN CHEM. CO. | kaken pharmaceutical | Kaken pharmaceuticals contact addresses | KAKEN PHARMACEUTICAL | kaken | .

Search for more companies in Chiba

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Kaken Pharmaceutical Co Limited